For the Inventor, By the Inventor

Enter assignee name

Montville, NJ, United States of America

Diatide, Inc.

USPTO Granted Patents = 80

Forward Citations = 382

Loading Chart...

Loading Chart...

17 inventors (with patents filed for the assignee):

Richard T Dean (75 out of 88 patents)

John Lister-James (49 out of 57 patents)

William McBride (19 out of 23 patents)

4. Scott Buttram (16 out of 19 patents)

5. Edgar R Civitello (14 out of 14 patents)

6. Daniel A Pearson (8 out of 18 patents)

7. Larry R Bush (5 out of 5 patents)

8. Robert S Lees (3 out of 20 patents)

9. John E Cyr (3 out of 5 patents)

10. Brian R Moyer (2 out of 3 patents)

11. Duane L Venton (1 out of 5 patents)

12. Francis S Markland, Jr (1 out of 16 patents)

13. Edward R Civitello (1 out of 1 patent)

14. Anton J Hopfinger (1 out of 2 patents)

15. Guy Lebreton (1 out of 1 patent)

Core Competencies:

Radiopharmaceutical Compositions

Technetium-99m Labeled Peptides

Calcitonin Receptor Binding Reagents

Somatostatin Derivatives

Antithrombotic Agents

Thrombus Imaging Agents

Radiolabeled Compounds

Peptide-Metal Chelate Conjugates

Cyclic Hexapeptide Somatostatin Analogues

Pharmaceutical Compositions

Imaging Inflammation

Vasoactive Intestinal Peptides

80 patents: Sort by Forward Citations

1. 6989138 - Stabilization of radiopharmaceutical compositions using hydrophilic thioethers and hydrophilic 6-hydroxy chromans (2006-01-24),

2. 6902718 - Stabilization of radiopharmaceutical compositions using hydrophilic thioethers (2005-06-07),

3. 6881396 - Stabilization of radiopharmaceutical compositions using hydrophilic 6-hydroxy-chromans (2005-04-19),

4. 6667389 - Technetium-99m labeled peptides for imaging (2003-12-23),

5. 6509001 - Calcitonin receptor binding reagents (2003-01-21),

6. 6479032 - Calcitonin receptor binding reagents (2002-11-12),

7. 6241965 - Somatostatin derivatives and their radiolabelled products (2001-06-05),

8. 6214316 - Somatostatin analogs (2001-04-10),

9. 6183722 - Somatostatin analogs (2001-02-06),

10. 6150329 - Multimeric antithrombotic agents (2000-11-21),

11. 6136782 - Multimeric antithrombotic agents (2000-10-24),

12. 6113878 - Technetium-99m labeled peptides for imaging (2000-09-05),

13. 6107459 - Technetium-99m labeled peptides for diagnostic imaging (2000-08-22),

14. 6093383 - Bisamine bisthiol radiolabel binding moieties (2000-07-25),

15. 6086850 - Calcitonin receptor binding reagents (2000-07-11),

Diatide, Inc. is a pharmaceutical company specializing in the development of targeted therapeutic drugs. With a focus on innovative solutions for cancer treatment, Diatide aims to improve patient outcomes and quality of life. Through extensive research and collaboration, the company has successfully brought several drug candidates to pre-clinical and clinical stages, demonstrating promising results. Diatide is committed to advancing the field of oncology and making a lasting impact in the fight against cancer.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

80 Patents

#1 in Montville, NJ

#203 in New Jersey

#4,438 in US

#9,062 in the World

Montville, NJ, United States of America

Diatide, Inc.

Forward Citations = 382

17 inventors:

Richard T Dean (75 out of 88 patents)

John Lister-James (49 out of 57 patents)

William McBride (19 out of 23 patents)

4. Scott Buttram (16 out of 19 patents)

5. Edgar R Civitello (14 out of 14 patents)

Please report any incorrect information to support@idiyas.com

Loading…